Health / Pharma
Novo Nordisk Ups Bid for Metsera Amidst Pfizer Competition
The race to dominate the obesity and diabetes drug market is heating up, with Novo Nordisk and Pfizer battling to acquire Metsera. This acquisition would bolster their pipelines with innovative treatments.